News


June 23, 2017

EnzBond awarded SynbiCITE funding

467afbc8-04ab-4c3b-9da9-7315dd41ccb9jpg

SynbiCITE has granted EnzBond £50,000 POC funding to develop a novel biocatalyst for the production of a blockbuster drug. Following the success of the project, this will be the first computation-only evolved enzyme applied to the production of a pharmaceutical compound on an industrial scale. The project will allow EnzBond to demonstrate its game-changing technology on the industrial target and will serve as a first step to develop a novel biocatalyst family for the highly desired reaction class.


December 6, 2016

EnzBond news on the Global University Venturing page

1cd79bad9db34e1ca2502cfbde7bc395png

Read more on Oxford spins out EnzBond



December 2, 2016

EnzBond is officially incorporated

249ef0fbeb174188beb4f5892c75fe4fjpg
EnzBond Limited - a spin-out company from Oxford University has officially incorporated to bring fast, cost-effective enzyme development to market.

Read more on the Oxford University news page